Mylan said on Monday the auto-injector EpiPen pretax profits were higher than it told Congress, according to Dow Jones. » Read More
The nation's uninsured rate would spike under Trump's health plan, but fall further under Clinton's, a study finds.
The optics of Mylan CEO Heather Bresch's use of a private jet to fly to her testimony before Congress may not have been ideal.
Mylan also faces heat from multiple regulatory and legal agencies over huge cost increases for the anti-allergy auto-injectors.
A drugmaker producing acne creams has raised the price of two of its treatments to almost $10K a tube, the Financial Times reports.
Mylan CEO Heather Bresch is set to testify Wednesday before a House committee over sky-high price hikes for lifesaving EpiPens.
Less than 10 percent of authorized doctors prescribe the medication buprenorphine to more than 75 patients.
Shares of Sarepta Therapeutics jumped more than 13 percent in Tuesday trade after closing higher Monday on government approval of its drug.
GlaxoSmithKline said it had chosen its head of consumer health care, Emma Walmsley, as its new CEO, after considering other candidates.
Despite rising Obamacare prices, the total premiums paid in many cases are less than work-based coverage.
Shares of Sarepta Therapeutics briefly surge after the FDA approved its muscular dystrophy drug eteplirsen.
RSV — or respiratory syncytial virus — has been a problem that's thwarted medicine for more than half a century.
Workers are being forced to pay more out of pocket for health care than in the past.
People in consumer-directed health plans tend to pay much more out of pocket for health care than others despite lower use.
Employers may be leery about shifting more health costs to their employees, according to the results from two health benefits surveys.
Republicans want to repeal Obamacare, but millions of people could lose coverage if that happens.
The president dropped by a meeting with insurers Monday, and wrote all insurance companies selling Obamacare plans.
Get the best of CNBC in your inbox